TREACE MEDICAL CONCEPTS INC (TMCI) Stock Income Statement
NASDAQ:TMCI - Nasdaq - US89455T1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 210.82M | 209.36M | 187.12M | 141.80M | 94.40M | |||
| Cost Of Goods | 41.64M | 41.09M | 35.18M | 27.50M | 17.80M | |||
| Gross Profit | 169.18M | 168.26M | 151.94M | 114.30M | 76.60M | |||
| Operating Expenses | 221.48M | 223.95M | 203.37M | 149.20M | 93.10M | |||
| Research and Development | 20.89M | 20.59M | 15.44M | 13.60M | 10.20M | |||
| Selling, General, and Administrative Expenses | 200.59M | 203.36M | 187.93M | 135.60M | 82.90M | |||
| Operating Income | -52.30M | -55.69M | -51.43M | -34.80M | -16.50M | |||
| Interest Income/Expense | -1.07M | -379.00K | 1.56M | -3.20M | -4.00M | |||
| Other Income/Expense | 380.00K | 324.00K | 342.00K | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -4.80M | N/A | |||
| Income Before Taxes | -52.99M | -55.74M | -49.53M | -42.80M | -20.60M | |||
| Net Income | -52.99M | -55.74M | -49.53M | -42.80M | -20.70M | |||
| EBITDA | -43.33M | -47.27M | -46.08M | -32.67M | -15.81M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.85 | -0.90 | -0.81 | -0.77 | -0.43 | |||
| Non GAAP EPS | -0.80 | -0.85 | -0.81 | -0.77 | -0.41 | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.25% | 80.37% | 81.20% | 80.61% | 81.14% | |||
| Profit Margin | -25.13% | -26.63% | -26.47% | -30.18% | -21.93% | |||
| Operating Profit Margin | -24.81% | -26.60% | -27.48% | -24.54% | -17.48% | |||
All data in USD